Trials / Recruiting
RecruitingNCT05258448
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
The Effect of Radiotherapy on the Heart in Loco-regional Advanced NSCLC Patients Treated With Definitive Radiotherapy Measured by Cardiac MR
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with loco-regional NSCLC planned for curative treatment with chemoradiotherapy will be invited to participate in a prospective study; besides routine treatment, the patients will be followed with an ECG and cardiac MR for at least two years after radiotherapy treatment.
Detailed description
Definitive chemo-radiotherapy is the treatment of choice for loco-regional advanced non-small cell lung cancer (LA-NSCLC). However, the treatment is associated with a range of side effects with radiation pneumonitis and esophagitis. In addition, the toxicity of the heart in lung cancer patients treated with radiotherapy has been offered less consideration. Therefore, it is essential to investigate the possible early and late toxicity to the heart and the baseline cardiac status of these patients. This study will describe cardiac comorbidity before radiotherapy treatment by a thorough history. Furthermore, we will evaluate heart function and evaluate possible heart disease by an ECG and cardiac MR. Patients will be followed with ECG and cardiac MR for two years after radiotherapy, detecting structural changes caused by radiotherapy and subclinical disease after radiotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Chemoradiotherapy | Cardiac Magnetic Resonance scan and ECG |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2024-08-01
- Completion
- 2026-10-01
- First posted
- 2022-02-28
- Last updated
- 2023-12-06
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05258448. Inclusion in this directory is not an endorsement.